[1] Dinndorf PA, Gootenberg J, Cohen MH, et al. FDA Drug Approval Summary: Pegaspargase(Oncaspar_) for the First-Line Treatment of Children with Acute Lymphoblastic Leukemia(ALL) [J],The oncologist. 2007;12:991-998. [2] 培门冬酶Ⅱ期临床试验协作组.培门冬酶与左旋门冬酰胺酶治疗儿童急性淋巴细胞白血病的随机对照研究[J].中华血液学杂志,2008;29:29-33. [3] Masetti R, Pession A. First-line treatment of acute lymphoblastic leukemia withpegasparaginase.biologics[J]:Target＆Therapy.2009;3:359-368. [4] Bodmer M, Sulz M, Stadlmann S, et al. Fatal Liver Failure in an Adult Patient with Acute Lymphoblastic Leukemia following Treatment[J]. with L-Asparaginase. Digestion 2006;74:28-32.
